RNAi-Mediated Knockdown of Cottontail Rabbit Papillomavirus Oncogenes Using Low-Toxicity Lipopolyplexes As a Paradigm to Treat Papillomavirus-Associated Cancers

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Oct 28

PMID 37896139

Authors

Uzma Ali

Michael Bette

Ghazala Ambreen

Shashank R Pinnapireddy

Imran Tariq

Andre Marquardt

Boris A Stuck

Udo Bakowsky

Robert Mandic

Affiliations

Soon will be listed here.

Abstract

The cottontail rabbit papillomavirus (CRPV)-associated VX2 carcinoma of the New Zealand White rabbit serves as a model system for human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCCs). The aim of this study was to evaluate the tumor-inhibiting effect of RNAi-mediated knockdown of the CRPV oncogenes, E6 and E7, using siRNA-loaded lipopolyplexes (LPPs). VX2-carcinoma-derived cells were cultured for up to 150 passages. In addition, CRPV E6 and E7 oncogenes were transiently expressed in COS-7 cells. Efficiency and safety of LPPs were evaluated in both VX2 cells and the COS-7 cell line. Both of these in vitro CRPV systems were validated and characterized by fluorescence microscopy, Western blot, and RT-qPCR. Efficient knockdown of CRPV E6 and E7 was achieved in VX2 cells and COS-7 cells pretransfected with CRPV E6 and E7 expression vectors. Knockdown of CRPV oncogenes in VX2 cells resulted in reduced viability, migration, and proliferation and led to a G0/G1 block in the cell cycle. CRPV E6 and E7 siRNA-loaded LPPs could represent promising therapeutic agents serving as a paradigm for the treatment of papillomavirus-positive cancers and could be of value for the treatment of CRPV-associated diseases in the rabbit such as papillomas and cancers of the skin.

Citing Articles

Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies".

Bousbaa H Pharmaceutics. 2025; 17(1.

PMID: 39861702 PMC: 11769241. DOI: 10.3390/pharmaceutics17010054.

References

Shope R, Hurst E . INFECTIOUS PAPILLOMATOSIS OF RABBITS : WITH A NOTE ON THE HISTOPATHOLOGY. J Exp Med. 2009; 58(5):607-24. PMC: 2132321. DOI: 10.1084/jem.58.5.607. View

Meyers C, HARRY J, Lin Y, WETTSTEIN F . Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J Virol. 1992; 66(3):1655-64. PMC: 240904. DOI: 10.1128/JVI.66.3.1655-1664.1992. View

Muench P, Probst S, Schuetz J, Leiprecht N, Busch M, Wesselborg S . Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res. 2010; 70(17):6913-24. DOI: 10.1158/0008-5472.CAN-10-1307. View

Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F . siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 2003; 22(38):5938-45. DOI: 10.1038/sj.onc.1206894. View

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D, Pineros M . Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018; 144(8):1941-1953. DOI: 10.1002/ijc.31937. View

Georges E, Breitburd F, Jibard N, Orth G . Two Shope papillomavirus-associated VX2 carcinoma cell lines with different levels of keratinocyte differentiation and transplantability. J Virol. 1985; 55(1):246-50. PMC: 254922. DOI: 10.1128/JVI.55.1.246-250.1985. View

Linder B, Weirauch U, Ewe A, Uhmann A, Seifert V, Mittelbronn M . Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model. Cancers (Basel). 2019; 11(3). PMC: 6468565. DOI: 10.3390/cancers11030333. View

Ke N, Wang X, Xu X, Abassi Y . The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol. 2011; 740:33-43. DOI: 10.1007/978-1-61779-108-6_6. View

Kurosaki T, Kawakami S, Higuchi Y, Suzuki R, Maruyama K, Sasaki H . Development of anionic bubble lipopolyplexes for efficient and safe gene transfection with ultrasound exposure in mice. J Control Release. 2014; 176:24-34. DOI: 10.1016/j.jconrel.2013.12.023. View

10.

Li S, Ren G, Jin W, Guo W . Establishment and characterization of a rabbit oral squamous cell carcinoma cell line as a model for in vivo studies. Oral Oncol. 2010; 47(1):39-44. DOI: 10.1016/j.oraloncology.2010.10.003. View

11.

KREIDER J, Bartlett G . Shope rabbit papilloma--carcinoma complex. A model system of HPV infections. Clin Dermatol. 1985; 3(4):20-6. DOI: 10.1016/0738-081x(85)90046-x. View

12.

OSATO T, Ito Y . In vitro cultivation and immunofluorescent studies of transplantable carcinomas Vx2 and Vx7. Persistence of a Shope virus-related antigenic substance in the cells of both tumors. J Exp Med. 1967; 126(5):881-6. PMC: 2138408. DOI: 10.1084/jem.126.5.881. View

13.

Hadinoto K, Sundaresan A, Cheow W . Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013; 85(3 Pt A):427-43. DOI: 10.1016/j.ejpb.2013.07.002. View

14.

GOLDBERG H, Lockwood S, Wyatt S, Crossett L . Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer. 1994; 74(2):565-72. DOI: 10.1002/1097-0142(19940715)74:2<565::aid-cncr2820740206>3.0.co;2-i. View

15.

Pal A, Kundu R . Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy. Front Microbiol. 2020; 10:3116. PMC: 6985034. DOI: 10.3389/fmicb.2019.03116. View

16.

Tagalakis A, Maeshima R, Yu-Wai-Man C, Meng J, Syed F, Wu L . Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: Targetable nanocomplexes for in vivo nucleic acid delivery. Acta Biomater. 2017; 51:351-362. DOI: 10.1016/j.actbio.2017.01.048. View

17.

Blitzer G, Smith M, Harris S, Kimple R . Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2014; 88(4):761-70. PMC: 3990872. DOI: 10.1016/j.ijrobp.2013.08.029. View

18.

Zhu D, Ye M, Zhang W . E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells. Int J Clin Exp Pathol. 2015; 8(5):4981-9. PMC: 4503063. View

19.

Mandic R, Dunne A, Eikelkamp N, Ramaswamy A, Schulz S, Teymoortash A . Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit. Anticancer Res. 2003; 22(6A):3281-4. View

20.

Ewe A, Panchal O, Pinnapireddy S, Bakowsky U, Przybylski S, Temme A . Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo. Nanomedicine. 2016; 13(1):209-218. DOI: 10.1016/j.nano.2016.08.005. View